Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
CPDM supports the characterization of patient derived models using various genomic and molecular approaches. Our standard approaches include:
Once characterization data is acquired, data will be uploaded to a private instance of cBioPortal for analysis and visualization.
Please email email@example.com to learn more about our model characterization services.